Nephrogenic adenoma of the bladder in renal transplant recipients: a report of 9 cases with assessment of deoxyribonucleic acid ploidy and long-term followup.
Nephrogenic adenoma of the bladder in renal transplant recipients: a report of 9 cases with assessment of deoxyribonucleic acid ploidy and long-term followup.
复制标题
肾移植受者膀胱肾源性腺瘤：9例脱氧核糖核酸倍体评估及长期随访报告。
DOI：
10.1016/s0022-5347(01)65932-9
复制
发表时间：
1996
期刊：
影响因子：
--
通讯作者：
P. Mangin
中科院分区：
文献类型：
--
作者：
G. Fournier;P. Menut;M. Moal;E. Hardy;A. Volant;P. Mangin
PurposeWe evaluated the outcome of nephrogenic adenoma, a benign tumor rarely encountered in renal transplant recipients.Materials and MethodsBetween 1985 and 1993, 9 renal transplant recipients with a nephrogenic bladder adenoma removed by endoscopic resection were followed for 24 to 88 months (mean 40). Tumor deoxyribonucleic acid ploidy was assessed by flow cytometry at diagnosis and/or relapse.ResultsThe relapse rate was 88 percent. The tumors were diploid and of low proliferating potential, and showed no malignant transformation.ConclusionsOur study confirms the lack of premalignant potential of nephrogenic adenomas. However, since transplant recipients might be at increased risk for bladder cancer, they should be followed closely.
